Mattias Bergqvist - Biovica (Sweden)

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 56 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Role of Serum Thymidine Kinase 1 Activity in Neoadjuvant-Treated HER2-positive Breast Cancer: Biomarker Analysis from the Swedish Phase II Randomized PREDIX HER2 Trial

Yajing Zhu,Ioannis Zerdes,Alexios Matikas, Ivette Raices Cruz,Mattias Bergqvist,Ellinor Elinder,Ana Bosch,Henrik Lindman,Zakaria Einbeigi,Anne Andersson,Lena Carlsson,Ann Charlotte Dreifaldt,Erika Isaksson-Friman,Mats Hellstrom,Hemming Johansson,Kang Wang,Jonas C. S. Bergh,Thomas Hatschek,Theodoros Foukakis

BREAST CANCER RESEARCH AND TREATMENTno. 2 (2024): 299-308

引用0浏览0WOS引用

Abstract PO1-15-06: Serum thymidine kinase activity as a “real-time” clinical biomarker of tumor response to CDK4/6 inhibition in hormone receptor positive (HR+), HER2 negative (HER2-) metastatic breast cancer

Nusayba Bagegni,Amy Williams,Isabella Grigsby,Mattias Bergqvist,Katherine Clifton,Cynthia Ma

Cancer Researchno. 9_Supplement (2024): PO1-15

引用0浏览0引用

Abstract 7625: the Liquid Biomarker Thymidine Kinase Activity Reflecting Proliferation Rate Can Provide Guidance in Drug Development and Address Project Optimus

Mattias Bergqvist,Hanna Ritzen,Amy Williams

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Thymidine Kinase Activity - A Liquid Biomarker Reflecting Proliferation Rate and Treatment Efficacy in Solid Tumors Provides Unique Guidance in Oncology Trials and Drug Development

Mattias K. Bergqvist,Hanna Ritzen,Amy Williams

CANCER RESEARCH（2023）

引用0浏览0引用

Figure S3 from Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy

Vasu R. Sah,Henrik Jespersen,Joakim Karlsson,Lisa M. Nilsson,Mattias Bergqvist,Iva Johansson,Ana Carneiro,Hildur Helgadottir,Max Levin,Gustav Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas A. Nilsson,Lars Ny

openalex（2023）

引用0浏览0引用

Abstract OT3-11-01: TK IMPACT: Treatment Monitoring of Hormone Receptor Positive (HR+), HER2 Negative (HER2-) Metastatic Breast Cancer (MBC) Patients Receiving CDK 4/6 Inhibitors (cdk4/6i) with DiviTum® Thymidine Kinase 1 Activity

Nusayba A. Bagegni,Isabella Grigsby,Leslie Nehring,Jingqin Luo,Jennifer Powers Carson, David W. Gibson,Meghan Horvath,Katherine K. Clifton,Foluso O. Ademuyiwa,Rama Suresh,Ashley Frith,Andrew A. Davis, Lindsay L. Peterson,Ron Bose,Amy Williams,Mattias Bergqvist,Cynthia Ma

Cancer Researchno. 5_Supplement (2023): OT3-11

引用0浏览0引用

A Subset of Non-Small Cell Lung Cancer Patients Treated with Pemetrexed Show 18F-Fluorothymidine "flare" on Positron Emission Tomography

Preetha Aravind,Sanjay Popat,Tara D. Barwick,Neil Soneji,Mark Lythgoe,Katherina B. Sreter,Jingky P. Lozano-Kuehne,Mattias Bergqvist,Neva Patel,Eric O. Aboagye,Laura M. Kenny

Cancersno. 14 (2023): 3718-3718

引用0浏览0WOS引用

Table S2 from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Costanza Paoletti,William E. Barlow,Erin F. Cobain,Mattias Bergqvist, Rita S. Mehta,Julie R. Gralow,Gabriel N. Hortobagyi,Kathy S. Albain,Lajos Pusztai,Priyanka Sharma,Andrew K. Godwin,Alastair M. Thompson,Daniel F. Hayes,James M. Rae

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn